Clinical Endoscopy

The Korean Society of Gastrointestinal Endoscopy (대한소화기내시경학회)
권호 표지
DOI QR코드

DOI QR Code

Diagnostic value of homogenous delayed enhancement in contrast-enhanced computed tomography images and endoscopic ultrasound-guided tissue acquisition for patients with focal autoimmune pancreatitis

  • Keisuke Yonamine (Department of Gastroenterology, Sendai City Medical Center) ;
  • Shinsuke Koshita (Department of Gastroenterology, Sendai City Medical Center) ;
  • Yoshihide Kanno (Department of Gastroenterology, Sendai City Medical Center) ;
  • Takahisa Ogawa (Department of Gastroenterology, Sendai City Medical Center) ;
  • Hiroaki Kusunose (Department of Gastroenterology, Sendai City Medical Center) ;
  • Toshitaka Sakai (Department of Gastroenterology, Sendai City Medical Center) ;
  • Kazuaki Miyamoto (Department of Gastroenterology, Sendai City Medical Center) ;
  • Fumisato Kozakai (Department of Gastroenterology, Sendai City Medical Center) ;
  • Hideyuki Anan (Department of Gastroenterology, Sendai City Medical Center) ;
  • Haruka Okano (Department of Gastroenterology, Sendai City Medical Center) ;
  • Masaya Oikawa (Department of Gastroenterological Surgery, Sendai City Medical Center) ;
  • Takashi Tsuchiya (Department of Gastroenterological Surgery, Sendai City Medical Center) ;
  • Takashi Sawai (Department of Pathology, Sendai City Medical Center) ;
  • Yutaka Noda (Department of Gastroenterology, Sendai City Medical Center) ;
  • Kei Ito (Department of Gastroenterology, Sendai City Medical Center)
  • Received : 2022.05.09
  • Accepted : 2022.07.27
  • Published : 2023.07.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background/Aims: We aimed to investigate (1) promising clinical findings for the recognition of focal type autoimmune pancreatitis (FAIP) and (2) the impact of endoscopic ultrasound (EUS)-guided tissue acquisition (EUS-TA) on the diagnosis of FAIP. Methods: Twenty-three patients with FAIP were involved in this study, and 44 patients with resected pancreatic ductal adenocarcinoma (PDAC) were included in the control group. Results: (1) Multivariate analysis revealed that homogeneous delayed enhancement on contrast-enhanced computed tomography was a significant factor indicative of FAIP compared to PDAC (90% vs. 7%, p=0.015). (2) For 13 of 17 FAIP patients (76.5%) who underwent EUS-TA, EUS-TA aided the diagnostic confirmation of AIPs, and only one patient (5.9%) was found to have AIP after surgery. On the other hand, of the six patients who did not undergo EUS-TA, three (50.0%) underwent surgery for pancreatic lesions. Conclusions: Homogeneous delayed enhancement on contrast-enhanced computed tomography was the most useful clinical factor for discriminating FAIPs from PDACs. EUS-TA is mandatory for diagnostic confirmation of FAIP lesions and can contribute to a reduction in the rate of unnecessary surgery for patients with FAIP.

Keywords

Acknowledgement

We thank Fumiyoshi Fujishima, MD, PhD, Department of Pathology, Tohoku University School of Medicine and Miwa Uzuki, MD, PhD, Department of Nursing, Faculty of Medical Science and Welfare, Tohoku Bunka Gakuen University for histological evaluations using cytological specimens and resected specimens from all subjects, and all staff in the Department of Pathology at Sendai City Medical Center for immunostaining all specimens in this case. In addition, we are grateful to Dr. Brian Breedlove, Associate Professor, Tohoku University School of Science, for the English proofreading.

References

  1. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003;38:982-984.  https://doi.org/10.1007/s00535-003-1175-y
  2. Kamisawa T, Funata N, Hayashi Y, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003;52:683-687.  https://doi.org/10.1136/gut.52.5.683
  3. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006;41:626-631.  https://doi.org/10.1007/s00535-006-1868-0
  4. Kawaguchi K, Koike M, Tsuruta K, et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991;22:387-395.  https://doi.org/10.1016/0046-8177(91)90087-6
  5. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011;40:352-358.  https://doi.org/10.1097/MPA.0b013e3182142fd2
  6. Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013;62:1771-1776.  https://doi.org/10.1136/gutjnl-2012-303617
  7. Chang MC, Liang PC, Jan S, et al. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels. Pancreatology 2014;14:366-372.  https://doi.org/10.1016/j.pan.2014.07.010
  8. Pak LM, Schattner MA, Balachandran V, et al. The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma. HPB (Oxford) 2018;20:182-187.  https://doi.org/10.1016/j.hpb.2017.09.001
  9. Furuhashi N, Suzuki K, Sakurai Y, et al. Differentiation of focal-type autoimmune pancreatitis from pancreatic carcinoma: assessment by multiphase contrast-enhanced CT. Eur Radiol 2015;25:1366-1374.  https://doi.org/10.1007/s00330-014-3512-3
  10. He C, Rong D, Hu W, et al. A feasible CT feature to differentiate focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma. Cancer Med 2019;8:6250-6257.  https://doi.org/10.1002/cam4.2526
  11. Zaheer A, Singh VK, Akshintala VS, et al. Differentiating autoimmune pancreatitis from pancreatic adenocarcinoma using dual-phase computed tomography. J Comput Assist Tomogr 2014;38:146-152.  https://doi.org/10.1097/RCT.0b013e3182a9a431
  12. Takahashi N, Fletcher JG, Hough DM, et al. Autoimmune pancreatitis: differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual-phase CT. AJR Am J Roentgenol 2009;193:479-484.  https://doi.org/10.2214/AJR.08.1883
  13. Lee-Felker SA, Felker ER, Kadell B, et al. Use of MDCT to differentiate autoimmune pancreatitis from ductal adenocarcinoma and interstitial pancreatitis. AJR Am J Roentgenol 2015;205:2-9.  https://doi.org/10.2214/AJR.14.14059
  14. Sugumar A, Levy MJ, Kamisawa T, et al. Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut 2011;60:666-670.  https://doi.org/10.1136/gut.2010.207951
  15. Kanno A, Masamune A, Fujishima F, et al. Diagnosis of autoimmune pancreatitis by EUS-guided FNA using a 22-gauge needle: a prospective multicenter study. Gastrointest Endosc 2016;84:797-804.  https://doi.org/10.1016/j.gie.2016.03.1511
  16. Morishima T, Kawashima H, Ohno E, et al. Prospective multicenter study on the usefulness of EUS-guided FNA biopsy for the diagnosis of autoimmune pancreatitis. Gastrointest Endosc 2016;84:241-248.  https://doi.org/10.1016/j.gie.2016.01.016
  17. Iwashita T, Yasuda I, Doi S, et al. Use of samples from endoscopic ultrasound-guided 19-gauge fine-needle aspiration in diagnosis of autoimmune pancreatitis. Clin Gastroenterol Hepatol 2012;10:316-322.  https://doi.org/10.1016/j.cgh.2011.09.032
  18. Kurita A, Yasukawa S, Zen Y, et al. Comparison of a 22-gauge Franseen-tip needle with a 20-gauge forward-bevel needle for the diagnosis of type 1 autoimmune pancreatitis: a prospective, randomized, controlled, multicenter study (COMPAS study). Gastrointest Endosc 2020;91:373-381.  https://doi.org/10.1016/j.gie.2019.10.012
  19. Ishikawa T, Kawashima H, Ohno E, et al. Usefulness of endoscopic ultrasound-guided fine-needle biopsy for the diagnosis of autoimmune pancreatitis using a 22-gauge Franseen needle: a prospective multicenter study. Endoscopy 2020;52:978-985.  https://doi.org/10.1055/a-1183-3583
  20. Koshita S, Ito K, Fujita N, et al. Localized autoimmune pancreatitis, 9 mm in size, without strictures of the main pancreatic duct. Gastrointest Endosc 2012;75:920-922.  https://doi.org/10.1016/j.gie.2011.05.010
  21. Cao Z, Tian R, Zhang T, et al. Localized autoimmune pancreatitis: report of a case clinically mimicking pancreatic cancer and a literature review. Medicine (Baltimore) 2015;94:e1656. 
  22. Noda Y, Fujita N, Kobayashi G, et al. Diagnostic efficacy of the cell block method in comparison with smear cytology of tissue samples obtained by endoscopic ultrasound-guided fine-needle aspiration. J Gastroenterol 2010;45:868-875.  https://doi.org/10.1007/s00535-010-0217-5
  23. Sumimoto K, Uchida K, Mitsuyama T, et al. A proposal of a diagnostic algorithm with validation of international consensus diagnostic criteria for autoimmune pancreatitis in a Japanese cohort. Pancreatology 2013;13:230-237.  https://doi.org/10.1016/j.pan.2013.02.010
  24. Hewitt MJ, McPhail MJ, Possamai L, et al. EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis. Gastrointest Endosc 2012;75:319-331.  https://doi.org/10.1016/j.gie.2011.08.049
  25. Khan MA, Grimm IS, Ali B, et al. A meta-analysis of endoscopic ultrasound-fine-needle aspiration compared to endoscopic ultrasound-fine-needle biopsy: diagnostic yield and the value of onsite cytopathological assessment. Endosc Int Open 2017;5:E363-E375.  https://doi.org/10.1055/s-0043-101693
  26. Chen G, Liu S, Zhao Y, et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer: a meta-analysis. Pancreatology 2013;13:298-304. https://doi.org/10.1016/j.pan.2013.01.013